Literature DB >> 9555944

Binding and intracellular trafficking of lipoprotein lipase and triacylglycerol-rich lipoproteins by liver cells.

R P Casaroli-Marano1, R García, E Vilella, G Olivecrona, M Reina, S Vilaró.   

Abstract

The cellular mechanisms and pathways by which lipoprotein lipase (LPL) enhances the binding and uptake of lipoproteins remains unknown. Confocal and immunoelectron microscopy demonstrated that primary binding of bovine LPL (bLPL) occurs at the microvilli surface of HepG2 cells and hepatocytes. Internalized bLPL was associated with endocytic vesicles and multivesicular bodies. Quantitative immunofluorescence indicated that the presence of bLPL caused a marked increase in the cell-surface binding of DiI-conjugated triacylglycerol-rich lipoproteins (DiI-TRL). Confocal microscopy showed that when DiI-TRL was incubated with bLPL at 4 degrees C, the distributions of bound LPL and DiI-TRL were totally coincident, and covered the apical surface of both HepG2 cells and hepatocytes. When incubated separately, the time-courses of the internalization of fluorescence associated with DiI-TRL and bLPL were different: DiI-TRL was quickly internalized by both HepG2 cells and hepatocytes, and reached a plateau at 30 min, whereas intracellular LPL increased continuously, but more slowly in the same period. In the presence of bLPL, DiI-TRL was internalized progressively by HepG2 and by cultured hepatocytes for up to 1 h and no saturation was reached. At this time the intensity of labeling of bLPL was lower than of DiI-TRL and a higher number of DiI spots did not colocalize with bLPL immunofluorescence, suggesting that the ligands follow a different pathway after internalization. The data suggest that when lipoprotein lipase (LPL) is associated with the lipoproteins it directs them to specific endocytic pathways. A hypothetical model of the intracellular pathways followed by triacylglycerol-rich lipoproteins and LPL after internalization is proposed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555944

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Authors:  Qiang Deng; Jian-wei Zhai; Marie-Louise Michel; Jun Zhang; Jun Qin; Yu-ying Kong; Xin-xin Zhang; Agata Budkowska; Pierre Tiollais; Yuan Wang; You-hua Xie
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

2.  Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans.

Authors:  Raquel García-Olivas; Johan Hoebeke; Susanna Castel; Manuel Reina; Gunnar Fager; Florentina Lustig; Senén Vilaró
Journal:  Histochem Cell Biol       Date:  2003-10-14       Impact factor: 4.304

3.  Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.

Authors:  Patrick Maillard; Marine Walic; Philip Meuleman; Farzin Roohvand; Thierry Huby; Wilfried Le Goff; Geert Leroux-Roels; Eve-Isabelle Pécheur; Agata Budkowska
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

Review 4.  Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.

Authors:  Daniel Prieto; Pablo Oppezzo
Journal:  Molecules       Date:  2017-12-05       Impact factor: 4.411

5.  Effects of heparin on the uptake of lipoprotein lipase in rat liver.

Authors:  Lucyna Neuger; Senén Vilaró; Carmen Lopez-Iglesias; Jitendra Gupta; Thomas Olivecrona; Gunilla Olivecrona
Journal:  BMC Physiol       Date:  2004-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.